login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AKERO THERAPEUTICS INC (AKRO) Stock News
USA
- NASDAQ:AKRO -
US00973Y1082
-
Common Stock
54.33
USD
-0.02 (-0.04%)
Last: 11/18/2025, 8:00:00 PM
54.42
USD
+0.09 (+0.17%)
After Hours:
11/18/2025, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AKRO Latest News, Press Relases and Analysis
All
Press Releases
6 days ago - By: Bloomberg
Novo Nordisk Starts Selling Bonds to Fund Akero Acquisition
9 days ago - By: Stocktwits
- Mentions:
NVO
PFE
MTSR
VKTX
Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith
12 days ago - By: Halper Sadeh LLC
- Mentions:
JAMF
CADE
GES
Halper Sadeh LLC Encourages JAMF, CADE, AKRO, GES Shareholders to Contact the Firm to Discuss Their Rights
a month ago - By: Stocktwits
- Mentions:
SPY
QQQ
DIA
DAL
...
Delta Air Lines, Tilray Brands, UiPath, Akero Therapeutics, Apogee Therapeutics: Stocks Making The Biggest Moves Today
12 days ago - By: Akero Therapeutics Inc.
Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025
12 days ago - By: Akero Therapeutics Inc.
Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025
12 days ago - By: Brodsky & Smith LLC
- Mentions:
QRVO
FFWM
CCRD
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qorvo, Inc. (Nasdaq – QRVO), First Foundation Inc. (NYSE – FFWM), Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD)
20 days ago - By: Halper Sadeh LLC
- Mentions:
AL
FFWM
HNI
Halper Sadeh LLC Encourages AL, FFWM, AKRO, HNI Shareholders to Contact the Firm to Discuss Their Rights
21 days ago - By: Brodsky & Smith LLC
- Mentions:
QRVO
FFWM
CCRD
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qorvo, Inc. (Nasdaq – QRVO), First Foundation Inc. (NYSE – FFWM), Akero Therapeutics, Inc. (Nasdaq – AKRO), CoreCard Corporation (NYSE – CCRD)
a month ago - By: Halper Sadeh LLC
- Mentions:
CCRD
PBBK
Halper Sadeh LLC Investigates AKRO, CCRD, PBBK on Behalf of Shareholders
a month ago - By: Brodsky & Smith LLC
- Mentions:
CCRD
AL
PBBK
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD), PB Bankshares, Inc. (Nasdaq - PBBK), Air Lease Corporation (NYSE – AL)
a month ago - By: Halper Sadeh LLC
- Mentions:
TRUE
PCH
ATXS
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates TRUE, AKRO, PCH, ATXS on Behalf of Shareholders
a month ago - By: Brodsky & Smith LLC
- Mentions:
CCRD
PBBK
AL
EEFT
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD), PB Bankshares, Inc. (Nasdaq - PBBK), Air Lease Corporation (NYSE – AL)
a month ago - By: Investor's Business Daily
- Mentions:
OMER
Omeros Catapults Almost 150% On A Surprise $2.1 Billion Deal With Novo Nordisk
a month ago - By: Bloomberg
Biotech Fund Beating 92% of Peers Sees More M&A Deals to Come
a month ago - By: Kahn Swick & Foti, LLC
Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO
a month ago - By: Zacks Investment Research
- Mentions:
CDTX
ALLO
CMMB
CDTX Stock Up on FDA's Breakthrough Therapy Tag for CD388 in Influenza
a month ago - By: Benzinga
- Mentions:
HSBC
KEYS
ALLO
DOCS
This Keysight Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
a month ago - By: The Motley Fool
Why Akero Therapeutics Stock Trounced the Market on Thursday
a month ago - By: Halper Sadeh LLC
- Mentions:
CCRD
AL
PBBK
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates AKRO, CCRD, AL, PBBK on Behalf of Shareholders
a month ago - By: Ademi LLP
Shareholder Alert: The Ademi Firm investigates whether Akero Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
a month ago - By: Brodsky & Smith LLC
- Mentions:
CCRD
AL
EEFT
PBBK
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD), PB Bankshares, Inc. (Nasdaq - PBBK), Air Lease Corporation (NYSE - AL)
a month ago - By: Benzinga
- Mentions:
ABVX
DGNX
NVX
SERV
...
Tilray Brands Posts Upbeat Results, Joins Byrna Technologies, Delta Air Lines And Other Big Stocks Moving Higher On Thursday
a month ago - By: Investor's Business Daily
- Mentions:
NVO
ETNB
Novo Nordisk Bulks Up Its Obesity-Tied Portfolio With $4.7 Billion Buyout
a month ago - By: Halper Sadeh LLC
AKRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akero Therapeutics, Inc. Is Fair to Shareholders
a month ago - By: Stocktwits
- Mentions:
SPY
QQQ
DIA
DJI
...
Dow Futures Inch Up As Wall Street Awaits Jerome Powell’s Speech: TSLA, NVO, DAL, PEP Among Stocks To Watch
a month ago - By: Stocktwits
- Mentions:
NVO
What’s Driving The Super Rally In Akero Shares On Thursday Morning?
a month ago - By: Akero Therapeutics Inc.
Akero Therapeutics to be Acquired by Novo Nordisk for up to $5.2 Billion
a month ago - By: Akero Therapeutics Inc.
Akero Therapeutics to be Acquired by Novo Nordisk for up to $5.2 Billion
a month ago - By: Akero Therapeutics Inc.
Akero Therapeutics to Present New Data from the Phase 2b SYMMETRY and HARMONY Studies of Efruxifermin at the 76th Annual AASLD The Liver Meeting® 2025
a month ago - By: Akero Therapeutics Inc.
Akero Therapeutics to Present New Data from the Phase 2b SYMMETRY and HARMONY Studies of Efruxifermin at the 76th Annual AASLD The Liver Meeting® 2025
Please enable JavaScript to continue using this application.